Pain Therapeutics (PTIE) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts PTIE Hot Sheet
Price: $1.24 --0%
Financial Fact:
Total operating expenses: 3.54M
Today's EPS Names:
AEHR, VFS, CMTL, More
Financial Fact:
Total operating expenses: 3.54M
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
Pain Therapeutics (NASDAQ: PTIE) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09).
At September 30, 2016, cash and investments were $21.8 million, compared to $24.6 million at June 30, 2016. The Company has no debt.
For earnings history and earnings-related data on Pain Therapeutics (PTIE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Some Said Inflation Risks Had Become More Skewed To Upside - FOMC Minutes
- Morgan Stanley Starts SHEIN Global Holdings (625:HK) at Overweight
- Levi Strauss beats profit forecasts, shares edge higher
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
